Company registration number 11623152 (England and Wales)
KOGS MEDICAL CONSULTANCY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
PAGES FOR FILING WITH REGISTRAR
Company Registration No. 11623152
KOGS MEDICAL CONSULTANCY LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2023
31 October 2023
- 1 -
2023
2022
£
£
£
£
Called up share capital not paid
5
5
Fixed assets
3,094
2,251
Current assets
389,304
322,274
Creditors: amounts falling due within one year
(18,572)
(19,793)
Net current assets
370,732
302,481
Total assets less current liabilities
373,831
304,737
Accruals and deferred income
(4,134)
(3,300)
Net assets
369,697
301,437
Capital and reserves
369,697
301,437
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees
At the year end, the directors owed the company a balance amounting to £75,164 (2022 - £72,690). During the year, amounts advanced to the directors were £894 (2022 - £11,188), repayments of £nil (2022 - £11,500) and interest of £1,580 (2022 - £1,475) was charged on the loan. The loan is repayable on demand and interest is charged at the HMRC official rate of interest.
2
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2023
2022
Number
Number
Employees
3
3
Company Registration No. 11623152
KOGS MEDICAL CONSULTANCY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2023
31 October 2023
- 2 -
KOGS Medical Consultancy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 117 Coleridge Way, Borehamwood, United Kingdom, WD6 2AF.
For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 30 October 2024 and are signed on its behalf by:
Dr G Da-Silva
Director